Abstract
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated. The neuroscience nurse must apply current knowledge about ticlopidine in the care for patients receiving ticlopidine therapy.
MeSH terms
-
Blood Platelets / drug effects
-
Blood Platelets / physiology
-
Cerebrovascular Disorders / blood
-
Cerebrovascular Disorders / prevention & control*
-
Humans
-
Intracranial Arteriosclerosis / blood
-
Intracranial Arteriosclerosis / complications
-
Intracranial Embolism and Thrombosis / blood
-
Intracranial Embolism and Thrombosis / prevention & control
-
Patient Education as Topic
-
Ticlopidine / adverse effects
-
Ticlopidine / pharmacokinetics
-
Ticlopidine / therapeutic use*